New Retina Radio by Eyetube
A podcast by Eyetube
191 Episodes
-
Vitreous Opacities: Hearing from Anterior and Posterior Segment Surgeons
Published: 01/10/2021 -
New Retina Radio Journal Club: Exudative AMD in FILLY and GATHER1 Results
Published: 17/09/2021 -
The Art of Drug Choice: International Panel in Wet AMD: Safety Data
Published: 10/09/2021 -
Vitreous Opacities: Innovations and the Decision to Operate
Published: 03/09/2021 -
The Art of Drug Choice: International Panel in Wet AMD: The Pipeline
Published: 01/09/2021 -
International Perspectives: DME
Published: 27/08/2021 -
The Art of Drug Choice: International Panel in Wet AMD: Phase 3 and Real-World Data to Watch
Published: 20/08/2021 -
New Retina Radio Journal Club: Data in the Wake of COVID-19
Published: 13/08/2021 -
The Art of Drug Choice: International Panel in Wet AMD: When and Why Switching Therapy Makes Sense
Published: 06/08/2021 -
Surgical options for treating AMD: Clinical Implications and Impact
Published: 29/07/2021 -
Advances in Gene Therapy for Wet AMD
Published: 26/07/2021 -
New Retina Radio Journal Club: Masking in Retina: Keeping Patients Safe from Bacterial Exposure
Published: 16/07/2021 -
Reconsidering treatment endpoints in real-world clinical practice: is achieving a favorable retreatment interval a goal of therapy?
Published: 09/07/2021 -
New Retina Radio Journal Club: Autologous Retina Transplant for Macular Holes
Published: 25/06/2021 -
Real-world impact of patients lost to follow-up: factors that drive nonadherence and strategies for encouraging better follow-up from patients
Published: 11/06/2021 -
ARVO 2021 Coverage: NGM621 and COOG2
Published: 04/06/2021 -
ARVO 2021: GATHER1 Study and CME After RRD Surgery
Published: 28/05/2021 -
ARVO 2021 Coverage: TENAYA/LUCERNE Results—and Is Fluid OK in Wet AMD?
Published: 21/05/2021 -
New Retina Radio Journal Club: Protocol W: How Might the Data Change Practice?
Published: 14/05/2021 -
New Retina Radio Journal Club: PRO Study Group Papers: Part 2
Published: 15/04/2021
New Retina Radio is a place to hear stories about retina that are told nowhere else.
